Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/10428194.2012.757764 | DOI Listing |
Pharm Res
February 2010
CNRS, UMR 8612, Physico-Chimie, Pharmacotechnie, Biopharmacie, Laboratoire Pharmacologie Cellulaire et Moléculaire des Anticancéreux, Faculté de Pharmacie, 5 rue J.B. Clément, Châtenay-Malabry, F-92296, France.
Purpose: To determine the better liposomal formulation incorporating the active metabolite of tamoxifen, 4-hydroxy-tamoxifen (4HT) and the biological impact of 4HT-pH-gradient liposomes on response to in vivo treatment.
Methods: Several pegylated liposomes were formulated by varying the composition of lipids, increasing external pH from 7.4 to 9.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!